VIVS - ORGANOVO HOLDINGS, INC.
1.83
-0.050 -2.732%
Share volume: 28,994
Last Updated: 03-06-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.17%
PREVIOUS CLOSE
CHG
CHG%
$1.88
-0.05
-0.03%
View ratios
| Fiscal Date | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
| Report Date | 08-05-2024 | 11-08-2024 | 02-19-2025 | 06-05-2025 | 08-12-2025 | |
| Total revenue | 39.000 K | 30.000 K | 24.000 K | 51.000 K | 37.000 K | |
| Cost of revenue | 2.000 K | 1.000 K | 2.000 K | 0.000 | 0.000 | |
| Gross profit | 37.000 K | 29.000 K | 22.000 K | 51.000 K | 37.000 K | |
| -21.62% | -24.14% | 131.82% | -27.45% | |||
| Operating expenses | 3.423 M | 2.637 M | 3.490 M | 3.205 M | 2.952 M | |
| Selling general and admin | 2.021 M | 1.653 M | 1.710 M | 2.346 M | 1.951 M | |
| Research and development | 1.402 M | 984.000 K | 1.780 M | 859.000 K | 1.001 M | |
| Total expenses | 3.423 M | 2.637 M | 3.490 M | 3.205 M | 2.952 M | |
| -22.96% | 32.35% | -8.17% | -7.89% | |||
| Operating income | -3.386 M | -2.608 M | -3.468 M | -3.154 M | -2.915 M | |
| Ebit | -3.386 M | -2.608 M | -3.468 M | -3.154 M | -2.915 M | |
| Pretax income | -3.342 M | -2.549 M | -3.447 M | 6.852 M | -2.843 M | |
| -23.73% | 35.23% | -298.78% | -141.49% | |||
| Income tax | 2.000 K | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -3.344 M | -2.549 M | -3.447 M | 6.852 M | -2.843 M | |
| 23.77% | -35.23% | 298.78% | -141.49% |